Immediate Impact
1 by Nobel laureates 3 from Science/Nature 57 standout
Citing Papers
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
2025 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Works of Eva Domingo‐Doménech being referenced
A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma
2020
A Phase 1b Study Investigating the Combination of the Tetravalent Bispecific NK Cell Engager AFM13 and Pembrolizumab in Patients with Relapsed/Refractory Hodgkin Lymphoma after Brentuximab Vedotin Failure: Updated Safety and Efficacy Data
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Eva Domingo‐Doménech | 1051 | 1282 | 339 | 106 | 2.1k | |
| Chiara Cattaneo | 443 | 1221 | 296 | 99 | 2.1k | |
| T. K. Chan | 548 | 489 | 367 | 70 | 1.7k | |
| Esa Jantunen | 645 | 843 | 194 | 73 | 2.0k | |
| Francesco Lauria | 1071 | 997 | 1609 | 103 | 2.9k | |
| Tsiporah B. Shore | 321 | 898 | 369 | 149 | 2.3k | |
| Marcus Hentrich | 498 | 1010 | 195 | 97 | 2.2k | |
| Gianpaolo Nadali | 625 | 603 | 348 | 68 | 1.9k | |
| Isidro Jarque | 429 | 641 | 430 | 152 | 2.5k | |
| Antonio Salar | 1702 | 1175 | 792 | 151 | 2.8k | |
| G.R. Morgenstern | 215 | 906 | 296 | 50 | 2.6k |
All Works
Login with ORCID to disown or claim papers
Loading papers...